{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04904588",
            "orgStudyIdInfo": {
                "id": "ACCESS"
            },
            "organization": {
                "fullName": "Center for International Blood and Marrow Transplant Research",
                "class": "NETWORK"
            },
            "briefTitle": "HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide",
            "officialTitle": "A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide for Patients With Hematologic Malignancies",
            "acronym": "ACCESS",
            "therapeuticArea": [
                "Rare Diseases",
                "Oncology and Hematology"
            ],
            "study": "hla-mismatched-unrelated-donor-hematopoietic-cell-transplantation-with-post-transplantation-cyclophosphamide"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-09-30",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-05-17",
            "studyFirstSubmitQcDate": "2021-05-26",
            "studyFirstPostDateStruct": {
                "date": "2021-05-27",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-22",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Center for International Blood and Marrow Transplant Research",
                "class": "NETWORK"
            },
            "collaborators": [
                {
                    "name": "National Marrow Donor Program",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a prospective, multi-center, Phase II study of hematopoietic cell transplantation (HCT) using human leukocyte antigen (HLA)-mismatched unrelated donors (MMUD) for peripheral blood stem cell transplant in adults and bone marrow stem cell transplant in children. Post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate mofetil (MMF) will be used for for graft versus host disease (GVHD) prophylaxis. This trial will study how well this treatment works in patients with hematologic malignancies."
        },
        "conditionsModule": {
            "conditions": [
                "Acute Lymphoblastic Leukemia",
                "Acute Myelogenous Leukemia",
                "Mixed Phenotype Acute Leukemia",
                "Acute Leukemia",
                "Myelodysplastic Syndromes",
                "Chronic Myelogenous Leukemia",
                "Chronic Lymphocytic Leukemia",
                "Lymphoma"
            ],
            "keywords": [
                "Lymphoma",
                "Leukemia",
                "Hematologic Diseases",
                "Myelodysplastic Syndromes",
                "Preleukemia",
                "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
                "Leukemia, Lymphocytic, Chronic, B-Cell",
                "Leukemia, Myeloid, Acute",
                "Leukemia, Biphenotypic, Acute",
                "Neoplasms by Histologic Type",
                "Neoplasms",
                "Lymphoproliferative Disorders",
                "Lymphatic Diseases",
                "Immunoproliferative Disorders",
                "Immune System Diseases",
                "Bone Marrow Diseases",
                "Precancerous Conditions",
                "Leukemia, Lymphoid",
                "Leukemia, B-Cell",
                "Leukemia, Myeloid",
                "Cyclophosphamide",
                "Mesna",
                "Tacrolimus",
                "Busulfan",
                "Fludarabine",
                "Total Body Irradiation",
                "Melphalan",
                "Mycophenolate mofetil",
                "Immunosuppressive Agents",
                "Immunologic Factors",
                "Physiological Effects of Drugs",
                "Hematopoietic Stem Cell Transplantation",
                "Unrelated Donors"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 300,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Regimen A (MAC: busulfan and fludarabine, PBSC HCT)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive:\n\n* Busulfan (\u2265 9 mg/kg total dose) IV or PO on days -6 to -3\n* Fludarabine (150 mg/m2 total dose) IV on days -6 to -2\n\nPatients receive a peripheral blood stem cell (PBSC) graft infusion from a mismatched unrelated donor on Day 0.",
                    "interventionNames": [
                        "Drug: Busulfan",
                        "Drug: Fludarabine",
                        "Procedure: PBSC Hematopoietic Stem Cell Transplantation (HSCT)",
                        "Drug: Post-transplant Cyclophosphamide",
                        "Drug: Mesna",
                        "Drug: Tacrolimus",
                        "Drug: Mycophenolate Mofetil",
                        "Other: Patient-Reported Outcomes"
                    ]
                },
                {
                    "label": "Regimen B (MAC: Fludarabine and TBI; PBSC HCT)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive:\n\n* Fludarabine (90 mg/m2 total dose) IV on days -7 to -5\n* Total body irradiation (TBI) (1200 cGy total dose) on days -4 to -1\n\nPatients receive a PBSC graft infusion from a mismatched unrelated donor on Day 0.",
                    "interventionNames": [
                        "Drug: Fludarabine",
                        "Radiation: Total-body irradiation",
                        "Procedure: PBSC Hematopoietic Stem Cell Transplantation (HSCT)",
                        "Drug: Post-transplant Cyclophosphamide",
                        "Drug: Mesna",
                        "Drug: Tacrolimus",
                        "Drug: Mycophenolate Mofetil",
                        "Other: Patient-Reported Outcomes"
                    ]
                },
                {
                    "label": "Regimen C (RIC: Fludarabine and Busulfan; PBSC HCT)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive:\n\n* Fludarabine (120-180 mg/m2 total dose) IV on days -6 to -2\n* Busulfan (less than or equal to 8 mg/kg PO or 6.4 mg/kg IV) on days -5 and -4\n\nPatients receive a PBSC graft infusion from a mismatched unrelated donor on Day 0.",
                    "interventionNames": [
                        "Drug: Busulfan",
                        "Drug: Fludarabine",
                        "Procedure: PBSC Hematopoietic Stem Cell Transplantation (HSCT)",
                        "Drug: Post-transplant Cyclophosphamide",
                        "Drug: Mesna",
                        "Drug: Tacrolimus",
                        "Drug: Mycophenolate Mofetil",
                        "Other: Patient-Reported Outcomes"
                    ]
                },
                {
                    "label": "Regimen D (RIC: Fludarabine and Melphalan; PBSC HCT)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive:\n\n* Fludarabine (120-180 mg/m2 total dose) IV on days -7 to -3\n* Melphalan (100-140 mg/m2) IV on day -1\n\nPatients receive a PBSC graft infusion from a mismatched unrelated donor on Day 0.",
                    "interventionNames": [
                        "Drug: Fludarabine",
                        "Drug: Melphalan",
                        "Procedure: PBSC Hematopoietic Stem Cell Transplantation (HSCT)",
                        "Drug: Post-transplant Cyclophosphamide",
                        "Drug: Mesna",
                        "Drug: Tacrolimus",
                        "Drug: Mycophenolate Mofetil",
                        "Other: Patient-Reported Outcomes"
                    ]
                },
                {
                    "label": "Regimen E (NMA: Fludarabine, Cyclophosphamide, TBI; PBSC HCT)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive:\n\n* Fludarabine (150 mg/m2 total dose) IV on days -6 to -2\n* Cyclophosphamide (29-50 mg/kg) IV on days -6 and -5\n* TBI (200 cGy) on day -1\n\nPatients receive a PBSC graft infusion from a mismatched unrelated donor on Day 0.",
                    "interventionNames": [
                        "Drug: Fludarabine",
                        "Radiation: Total-body irradiation",
                        "Drug: Cyclophosphamide",
                        "Procedure: PBSC Hematopoietic Stem Cell Transplantation (HSCT)",
                        "Drug: Post-transplant Cyclophosphamide",
                        "Drug: Mesna",
                        "Drug: Tacrolimus",
                        "Drug: Mycophenolate Mofetil",
                        "Other: Patient-Reported Outcomes"
                    ]
                },
                {
                    "label": "Regimen F (MAC: Busulfan and Cyclophosphamide; BM HCT)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive:\n\n* Busulfan (dosed by age and weight per institutional standards to target goal pharmacokinetic (PK) in range noted in protocol.) on days -6 to -3\n* Cyclophosphamide (100 mg/kg total dose) IV on days -2 and -1\n\nPatients receive a bone marrow (BM) graft infusion from a mismatched unrelated donor on Day 0.",
                    "interventionNames": [
                        "Drug: Busulfan",
                        "Drug: Cyclophosphamide",
                        "Procedure: Bone Marrow Hematopoietic Stem Cell Transplantation",
                        "Drug: Post-transplant Cyclophosphamide",
                        "Drug: Mesna",
                        "Drug: Tacrolimus",
                        "Drug: Mycophenolate Mofetil",
                        "Other: Patient-Reported Outcomes"
                    ]
                },
                {
                    "label": "Regimen G (MAC: Cyclophosphamide and TBI; BM HCT)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients receive:\n\n* Cyclophosphamide (100 mg/kg total dose) IV on days -5 and -4\n* TBI (1200 cGy total dose) on days -3, -2 and -1\n\nPatients receive a BM graft infusion from a mismatched unrelated donor on Day 0.",
                    "interventionNames": [
                        "Radiation: Total-body irradiation",
                        "Drug: Cyclophosphamide",
                        "Procedure: Bone Marrow Hematopoietic Stem Cell Transplantation",
                        "Drug: Post-transplant Cyclophosphamide",
                        "Drug: Mesna",
                        "Drug: Tacrolimus",
                        "Drug: Mycophenolate Mofetil",
                        "Other: Patient-Reported Outcomes"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Busulfan",
                    "description": "Given IV or PO pre-transplant as part of conditioning regimen",
                    "armGroupLabels": [
                        "Regimen A (MAC: busulfan and fludarabine, PBSC HCT)",
                        "Regimen C (RIC: Fludarabine and Busulfan; PBSC HCT)"
                    ],
                    "otherNames": [
                        "Busulfex\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Busulfan",
                    "description": "Given IV pre-transplant as part of conditioning regimen",
                    "armGroupLabels": [
                        "Regimen F (MAC: Busulfan and Cyclophosphamide; BM HCT)"
                    ],
                    "otherNames": [
                        "Busulfex\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fludarabine",
                    "description": "Given IV pre-transplant as part of conditioning regimen",
                    "armGroupLabels": [
                        "Regimen A (MAC: busulfan and fludarabine, PBSC HCT)",
                        "Regimen B (MAC: Fludarabine and TBI; PBSC HCT)",
                        "Regimen C (RIC: Fludarabine and Busulfan; PBSC HCT)",
                        "Regimen D (RIC: Fludarabine and Melphalan; PBSC HCT)",
                        "Regimen E (NMA: Fludarabine, Cyclophosphamide, TBI; PBSC HCT)"
                    ],
                    "otherNames": [
                        "Fludara\u00ae"
                    ]
                },
                {
                    "type": "RADIATION",
                    "name": "Total-body irradiation",
                    "description": "Administered pre-transplant as part of conditioning regimen",
                    "armGroupLabels": [
                        "Regimen B (MAC: Fludarabine and TBI; PBSC HCT)",
                        "Regimen E (NMA: Fludarabine, Cyclophosphamide, TBI; PBSC HCT)",
                        "Regimen G (MAC: Cyclophosphamide and TBI; BM HCT)"
                    ],
                    "otherNames": [
                        "TBI"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Cyclophosphamide",
                    "description": "Given IV pre-transplant as part of conditioning regimen",
                    "armGroupLabels": [
                        "Regimen E (NMA: Fludarabine, Cyclophosphamide, TBI; PBSC HCT)",
                        "Regimen F (MAC: Busulfan and Cyclophosphamide; BM HCT)",
                        "Regimen G (MAC: Cyclophosphamide and TBI; BM HCT)"
                    ],
                    "otherNames": [
                        "Cytoxan\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Melphalan",
                    "description": "Given IV pre-transplant as part of conditioning regimen",
                    "armGroupLabels": [
                        "Regimen D (RIC: Fludarabine and Melphalan; PBSC HCT)"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "PBSC Hematopoietic Stem Cell Transplantation (HSCT)",
                    "description": "Peripheral blood stem cell graft is infused from a mismatched unrelated donor on Day 0.",
                    "armGroupLabels": [
                        "Regimen A (MAC: busulfan and fludarabine, PBSC HCT)",
                        "Regimen B (MAC: Fludarabine and TBI; PBSC HCT)",
                        "Regimen C (RIC: Fludarabine and Busulfan; PBSC HCT)",
                        "Regimen D (RIC: Fludarabine and Melphalan; PBSC HCT)",
                        "Regimen E (NMA: Fludarabine, Cyclophosphamide, TBI; PBSC HCT)"
                    ],
                    "otherNames": [
                        "PBSC HSCT",
                        "PBSC HCT",
                        "PBSC Transplantation"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Bone Marrow Hematopoietic Stem Cell Transplantation",
                    "description": "Bone marrow graft is infused from a mismatched unrelated donor on Day 0.",
                    "armGroupLabels": [
                        "Regimen F (MAC: Busulfan and Cyclophosphamide; BM HCT)",
                        "Regimen G (MAC: Cyclophosphamide and TBI; BM HCT)"
                    ],
                    "otherNames": [
                        "BM HSCT",
                        "BM HCT",
                        "Bone Marrow Transplantation"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Post-transplant Cyclophosphamide",
                    "description": "Cyclophosphamide (50 mg/kg) is administered on Day +3 and on Day +4 post-transplant as an IV infusion over 1-2 hours.",
                    "armGroupLabels": [
                        "Regimen A (MAC: busulfan and fludarabine, PBSC HCT)",
                        "Regimen B (MAC: Fludarabine and TBI; PBSC HCT)",
                        "Regimen C (RIC: Fludarabine and Busulfan; PBSC HCT)",
                        "Regimen D (RIC: Fludarabine and Melphalan; PBSC HCT)",
                        "Regimen E (NMA: Fludarabine, Cyclophosphamide, TBI; PBSC HCT)",
                        "Regimen F (MAC: Busulfan and Cyclophosphamide; BM HCT)",
                        "Regimen G (MAC: Cyclophosphamide and TBI; BM HCT)"
                    ],
                    "otherNames": [
                        "Cytoxan\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Mesna",
                    "description": "Mesna is given in divided doses IV 30 min pre- and at 3, 6, and 8 hours post-cyclophosphamide.",
                    "armGroupLabels": [
                        "Regimen A (MAC: busulfan and fludarabine, PBSC HCT)",
                        "Regimen B (MAC: Fludarabine and TBI; PBSC HCT)",
                        "Regimen C (RIC: Fludarabine and Busulfan; PBSC HCT)",
                        "Regimen D (RIC: Fludarabine and Melphalan; PBSC HCT)",
                        "Regimen E (NMA: Fludarabine, Cyclophosphamide, TBI; PBSC HCT)",
                        "Regimen F (MAC: Busulfan and Cyclophosphamide; BM HCT)",
                        "Regimen G (MAC: Cyclophosphamide and TBI; BM HCT)"
                    ],
                    "otherNames": [
                        "Mesnex\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Tacrolimus",
                    "description": "Tacrolimus is given at a dose of 0.05 mg/kg PO or an IV dose of 0.03 mg/kg of ideal body weight (IBW) starting on Day +5 post-transplant with taper recommended at 90-100 days post HCT.",
                    "armGroupLabels": [
                        "Regimen A (MAC: busulfan and fludarabine, PBSC HCT)",
                        "Regimen B (MAC: Fludarabine and TBI; PBSC HCT)",
                        "Regimen C (RIC: Fludarabine and Busulfan; PBSC HCT)",
                        "Regimen D (RIC: Fludarabine and Melphalan; PBSC HCT)",
                        "Regimen E (NMA: Fludarabine, Cyclophosphamide, TBI; PBSC HCT)",
                        "Regimen F (MAC: Busulfan and Cyclophosphamide; BM HCT)",
                        "Regimen G (MAC: Cyclophosphamide and TBI; BM HCT)"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Mycophenolate Mofetil",
                    "description": "Mycophenolate mofetil (MMF) is given at a dose of 15 mg/kg three times daily IV or PO from Day +5 to Day +35 post-transplant.",
                    "armGroupLabels": [
                        "Regimen A (MAC: busulfan and fludarabine, PBSC HCT)",
                        "Regimen B (MAC: Fludarabine and TBI; PBSC HCT)",
                        "Regimen C (RIC: Fludarabine and Busulfan; PBSC HCT)",
                        "Regimen D (RIC: Fludarabine and Melphalan; PBSC HCT)",
                        "Regimen E (NMA: Fludarabine, Cyclophosphamide, TBI; PBSC HCT)",
                        "Regimen F (MAC: Busulfan and Cyclophosphamide; BM HCT)",
                        "Regimen G (MAC: Cyclophosphamide and TBI; BM HCT)"
                    ],
                    "otherNames": [
                        "MMF",
                        "Cellcept\u00ae"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Patient-Reported Outcomes",
                    "description": "Survey assessments will be administered to study participants pre- and post-transplant.",
                    "armGroupLabels": [
                        "Regimen A (MAC: busulfan and fludarabine, PBSC HCT)",
                        "Regimen B (MAC: Fludarabine and TBI; PBSC HCT)",
                        "Regimen C (RIC: Fludarabine and Busulfan; PBSC HCT)",
                        "Regimen D (RIC: Fludarabine and Melphalan; PBSC HCT)",
                        "Regimen E (NMA: Fludarabine, Cyclophosphamide, TBI; PBSC HCT)",
                        "Regimen F (MAC: Busulfan and Cyclophosphamide; BM HCT)",
                        "Regimen G (MAC: Cyclophosphamide and TBI; BM HCT)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Overall Survival",
                    "timeFrame": "1 year post HCT"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Event-free survival",
                    "description": "Defined as graft failure, relapse or progression of underlying disease, death, grade 3-4 acute GVHD, or NIH-severe chronic GVHD.",
                    "timeFrame": "1 year post-HCT"
                },
                {
                    "measure": "GVHD, relapse free survival",
                    "description": "Defined as relapse or progression of underling disease, graft failure, grade III-IV acute GVHD, chronic GVHD requiring systemic immune suppression, or death by any cause.",
                    "timeFrame": "1 year post-HCT"
                },
                {
                    "measure": "Modified GVHD, relapse free survival",
                    "description": "Defined as relapse or progression of underling disease, graft failure, grade III-IV acute GVHD, NIH moderate or severe chronic GVHD, or death by any cause.",
                    "timeFrame": "1 year post-HCT"
                },
                {
                    "measure": "Progression-free survival",
                    "timeFrame": "1 year post-HCT"
                },
                {
                    "measure": "Cumulative incidence of nonrelapse mortality",
                    "timeFrame": "Day +100 and 1 year post-HCT"
                },
                {
                    "measure": "Event-Free Survival based on donor HLA match grade and donor age (7/8 versus <7/8)",
                    "timeFrame": "1 year post-HCT"
                },
                {
                    "measure": "Overall Survival based on donor HLA match grade and donor age (7/8 versus <7/8)",
                    "timeFrame": "1 year post-HCT"
                },
                {
                    "measure": "Cumulative incidence of neutrophil recovery",
                    "description": "Defined as neutrophil count \u2265500/mm\\^3 for 3 consecutive days post-HCT.",
                    "timeFrame": "Day +100 post-HCT"
                },
                {
                    "measure": "Kinetics of neutrophil recovery",
                    "description": "Defined as the evaluation of the time it takes for neutrophil count recovery to occur in the study subjects.",
                    "timeFrame": "Day +100 post-HCT"
                },
                {
                    "measure": "Cumulative incidence of platelet recovery",
                    "description": "Defined as platelet count \u226520,000/mm\\^3 or \u226550,000/mm\\^3 with no platelet transfusions within seven days.",
                    "timeFrame": "Day +100 post-HCT"
                },
                {
                    "measure": "Kinetics of platelet recovery",
                    "description": "Defined as the evaluation of the time it takes for platelet count recovery to occur in the study subjects.",
                    "timeFrame": "Day +100 post-HCT"
                },
                {
                    "measure": "Cumulative incidence of primary graft failure",
                    "timeFrame": "Day +28 post-HCT"
                },
                {
                    "measure": "Donor chimerism",
                    "description": "Strata 2 and 3 only. Percent of donor chimerism via peripheral blood",
                    "timeFrame": "Day +100 post-HCT"
                },
                {
                    "measure": "Cumulative incidence of acute GVHD",
                    "timeFrame": "Day +100 post-HCT"
                },
                {
                    "measure": "Cumulative incidence of chronic GVHD",
                    "timeFrame": "1 year post-HCT"
                },
                {
                    "measure": "Cumulative incidence of BK and cytomegalovirus (CMV) viral infections",
                    "timeFrame": "Days +100 and +180 post-HCT"
                },
                {
                    "measure": "Cumulative incidence of relapse/progression",
                    "timeFrame": "1 year post-HCT"
                },
                {
                    "measure": "Incidence of cytokine release syndrome (CRS)",
                    "description": "Overall incidence of CRS of any grade and grade 3 or 4 CRS post-transplant",
                    "timeFrame": "Day +14 post-HCT"
                },
                {
                    "measure": "Cumulative incidence of secondary graft failure",
                    "timeFrame": "1 year post-HCT"
                },
                {
                    "measure": "Overall Toxicity",
                    "description": "To tabulate adverse events (AEs) experienced by recipients, defined as grade 3-5 unexpected and Grade 5 expected AEs, according to CTCAE version 5.0.",
                    "timeFrame": "1 year post-HCT"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Stratum 1 Recipient Inclusion Criteria:\n\n1. Age \\> 18 years and \\< 66 years (chemotherapy-based conditioning) or \\< 61 years (total body irradiation \\[TBI\\]-based conditioning) at the time of signing informed consent\n2. Planned MAC regimen as defined per protocol\n3. Available partially HLA-MMUD (4/8-7/8 at HLA-A, -B, -C, and -DRB1 is required) with age \\< 35 years\n4. Product planned for infusion is PBSC\n5. HCT Comorbidity Index (HCT-CI) \\< 5\n6. One of the following diagnoses:\n\n   1. Acute myeloid leukemia (AML) acute lymphoblastic leukemia (ALL), or other acute leukemia in 1st remission or beyond with \u2264 5% marrow blasts and no circulating blasts or evidence of extra-medullary disease. Documentation of bone marrow assessment will be accepted within 45 days prior to the anticipated start of conditioning.\n   2. Patients with myelodysplastic syndrome (MDS) with no circulating blasts and with \\< 10% blasts in the bone marrow (higher blast percentage allowed in MDS due to lack of differences in outcomes with \\< 5% or 5-10% blasts in MDS). Documentation of bone marrow assessment will be accepted within 45 days prior to the anticipated start of conditioning.\n7. Cardiac function: Left ventricular ejection fraction \\> 45% based on most recent echocardiogram or multigated acquisition scan (MUGA) results\n8. Estimated creatinine clearance \\> 60 mL/min calculated by equation\n9. Pulmonary function: diffusing capacity of the lungs for carbon monoxide (DLCO) corrected for hemoglobin \\> 50% and forced expiratory volume in first second (FEV1) predicted \\> 50% based on most recent pulmonary function test results\n10. Liver function acceptable per local institutional guidelines\n11. Karnofsky performance status (KPS) of \\> 70%\n12. Subjects \u2265 18 years of age or legally authorized representative must have the ability to give informed consent according to applicable regulatory and local institutional requirements.\n\nStratum 2 Recipient Inclusion Criteria\n\n1. Age \\> 18 years at the time of signing informed consent\n2. Planned NMA/RIC regimen as defined per protocol\n3. Available partially HLA-MMUD (4/8-7/8 at HLA-A, -B, -C, and -DRB1 is required) with age \\< 35 years\n4. Product planned for infusion is PBSC\n5. One of the following diagnoses:\n\n   1. Patients with acute leukemia or chronic myeloid leukemia (CML) with no circulating blasts, no evidence of extramedullary disease, and with \\< 5% blasts in the bone marrow. Documentation of bone marrow assessment will be accepted within 45 days prior to the anticipated start of conditioning.\n   2. Patients with MDS with no circulating blasts and with \\< 10% blasts in the bone marrow (higher blast percentage allowed in MDS due to lack of differences in outcomes with \\< 5% or 5-10% blasts in MDS.) Documentation of bone marrow assessment will be accepted within 45 days prior to the anticipated start of conditioning.\n   3. Patients with chronic lymphocytic leukemia (CLL) or other leukemias (including prolymphocytic leukemia) with chemosensitive disease at time of transplantation\n   4. Patients with lymphoma with chemosensitive disease at the time of transplantation\n6. Cardiac function: Left ventricular ejection fraction \\> 45% based on most recent echocardiogram or MUGA results with no clinical evidence of heart failure\n7. Estimated creatinine clearance \\> 60 mL/min calculated by equation\n8. Pulmonary function: DLCO corrected for hemoglobin \\> 50% and FEV1 predicted \\> 50% based on most recent pulmonary function test results\n9. Liver function acceptable per local institutional guidelines\n10. KPS of \\> 60%\n11. Subjects \u2265 18 years of age or legally authorized representative must have the ability to give informed consent according to applicable regulatory and local institutional requirements.\n\nStratum 3 Recipient Inclusion Criteria\n\n1. Age \\> 1 years and \\< 21 years at the time of signing informed consent\n2. Partially HLA-MMUD (4/8-7/8 at HLA-A, -B, -C, and -DRB1 is required) with age \\< 35 years\n3. Product planned for infusion is BM\n4. Planned MAC regimen as defined per protocol\n5. One of the following diagnosis:\n\n   1. AML in 1st remission or beyond with \u2264 5% marrow blasts, no circulating blasts or evidence of extra-medullary disease. Pre-transplant MRD testing will be performed as per standard of practice at the treating institution. Patients with any MRD status are eligible and should be enrolled at the discretion of provider. Documentation of bone marrow assessment will be accepted within 45 days prior to the anticipated start of conditioning.\n   2. Patients MDS with no circulating blasts and less than 10% blasts in the bone marrow. Documentation of bone marrow assessment will be accepted within 45 days prior to the anticipated start of conditioning.\n   3. ALL in 1st remission or beyond with \u2264 5% marrow blasts, no circulating blasts, or evidence of extra-medullary disease. Pre-transplant MRD testing will be performed as standard practice at the treating institution with the goal of achieving MRD of \\<0.01%. Patients with any MRD status are eligible and should be enrolled at the discretion of provider. Documentation of bone marrow assessment will be accepted within 45 days prior to the anticipated start of conditioning.\n   4. Other leukemia (mixed-phenotype acute leukemia \\[MPAL\\], CML, or other leukemia) in morphologic remission with \u2264 5% marrow blasts and no circulating blasts or evidence of extramedullary disease. Documentation of bone marrow assessment will be accepted within 45 days prior to the anticipated start of conditioning.\n   5. Chemotherapy sensitive lymphoma in at least partial remission (PR)\n6. KPS or Lansky performance score \u2265 70%\n7. Cardiac function: Left ventricular ejection fraction of \u2265 50% and shortening fraction of \u2265 27% based on most recent echocardiogram\n8. Glomerular Filtration Rate (GFR) of \u2265 60ml/min/1.73m2 measured by nuclear medicine scan or calculated from a 24 hour urine collection\n9. Pulmonary function: DLCO corrected for hemoglobin, FEV1, and Forced Vital Capacity (FVC) of \u226550% if able to perform pulmonary function tests. If unable to perform pulmonary function tests, must have a resting pulse oximetry of \\>92% without supplemental oxygen.\n10. Hepatic: Total bilirubin \u2264 2.5 mg/dL and alanine aminotransferase (ALT), aspartate aminotransferase (AST) \\< 3x the upper limit of normal\n11. Legal guardian permission must be obtained for subjects \\< 18 years of age. Pediatric subjects will be included in age appropriate discussion in order to obtain assent.\n12. Subjects \u2265 18 years of age or legally authorized representative must have the ability to give informed consent according to applicable regulatory and local institutional requirements.\n\nDonor Inclusion Criteria:\n\n1. Must be unrelated to the subject and high-resolution HLA-matched at 4/8, 5/8, 6/8, or 7/8 (HLA-A, -B, -C, and -DRB1)\n2. Donor must be typed at high-resolution for a minimum of HLA-A, -B, -C, -DRB1, -DQB1, and -DPB1\n3. Age \\> 18 years and \\< 35 years at the time of signing informed consent\n4. Meet the donor registries' medical suitability requirements for PBSC or BM donation\n5. Must undergo eligibility screening according to current Food and Drug Administration (FDA) requirements. Donors who do not meet one or more of the donor screening requirements may donate under urgent medical need.\n6. Must agree to donate PBSC (or BM for stratum 3)\n7. Must have the ability to give standard (non-study) informed consent according to applicable donor regulatory requirements\n\nRecipient Exclusion Criteria (Strata 1, 2 and 3):\n\n1. Suitable HLA-matched related or 8/8 high-resolution matched unrelated donor available\n2. Subject unwilling or unable to give informed consent, or unable to comply with the protocol including required follow-up and testing\n3. Primary myelofibrosis or myelofibrosis secondary to essential thrombocythemia, polycythemia vera, or MDS with grade 4 marrow fibrosis\n4. Subjects with a prior allogeneic HSC transplant\n5. Subjects with an autologous HSC transplant within the past 3 months\n6. Females who are breast-feeding or pregnant\n7. Uncontrolled bacterial, viral or fungal infection at the time of the transplant preparative regimen\n8. Concurrent enrollment on other interventional GVHD clinical trial (enrollment on supportive care trials may be allowed after discussion with Principal Investigators)\n9. Subjects who undergo desensitization to reduce anti-donor HLA antibody levels prior to transplant.\n10. Patients who are HIV+ with persistently positive viral load. HIV-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial.\n\nDonor Exclusion Criteria:\n\n1. Donor unwilling or unable to donate\n2. Recipient positive anti-donor HLA antibodies against a mismatched HLA in the selected donor determined by the presence of donor specific HLA antibodies (DSA) to any mismatched HLA allele/antigen at any of the following loci (HLA-A, -B, -C, -DRB1, DRB3, DRB4, DRB5, -DQA1, -DQB1, -DPA1, -DPB1) with median fluorescence intensity (MFI) \\>3000 by microarray-based single antigen bead testing. In patients receiving red blood cell or platelet transfusions, DSA evaluation must be performed or repeated post-transfusion and prior to donor mobilization and initiation of recipient preparative regimen.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "1 Year",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sarah Smith, RN, BSN",
                    "role": "CONTACT",
                    "phone": "763-406-5397",
                    "email": "ssmith23@nmdp.org"
                },
                {
                    "name": "Erin Leckrone",
                    "role": "CONTACT",
                    "phone": "763-406-5124",
                    "email": "eleckron@nmdp.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Steven Devine, MD",
                    "affiliation": "NMDP/Be The Match",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "City of Hope National Medical Center",
                    "status": "RECRUITING",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Monzr Al Malki, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "University of California San Francisco",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94143",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Aaron Logan, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Stanford University",
                    "status": "RECRUITING",
                    "city": "Stanford",
                    "state": "California",
                    "zip": "94305",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Sally Arai, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.42411,
                        "lon": -122.16608
                    }
                },
                {
                    "facility": "Colorado Blood Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Denver",
                    "state": "Colorado",
                    "zip": "80218",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alireza Eghtedar, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.73915,
                        "lon": -104.9847
                    }
                },
                {
                    "facility": "University of Florida Health Shands Hospital",
                    "status": "RECRUITING",
                    "city": "Gainesville",
                    "state": "Florida",
                    "zip": "32610",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Zenia Al-Mansour, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.65163,
                        "lon": -82.32483
                    }
                },
                {
                    "facility": "University of Miami Sylvester Cancer Center",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Antonio M Jimenez Jimenez, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "H. Lee Moffitt Cancer Center and Research Institute",
                    "status": "RECRUITING",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33612",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Farhad Khimani, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Children's Healthcare of Atlanta",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Muna Qayed, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Emory University Medical Center",
                    "status": "RECRUITING",
                    "city": "Atlanta",
                    "state": "Georgia",
                    "zip": "30322",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Amelia Langston, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.749,
                        "lon": -84.38798
                    }
                },
                {
                    "facility": "Northwestern University",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60611",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Kehinde Adekola, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "The University of Chicago",
                    "status": "RECRUITING",
                    "city": "Chicago",
                    "state": "Illinois",
                    "zip": "60637",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Satyajit Kosuri, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.85003,
                        "lon": -87.65005
                    }
                },
                {
                    "facility": "University of Maryland Medical Center",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Nancy Hardy, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21231",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Javier Bolanos Meade, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Tufts Medical Center",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02111",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Zheng (Frank) Zhou, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Dana Farber Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mahasweta Gooptu, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "University of Michigan Medical Center - Mott Children's Hospita",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Ann Arbor",
                    "state": "Michigan",
                    "zip": "48109",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.27756,
                        "lon": -83.74088
                    }
                },
                {
                    "facility": "Karmanos Cancer Institute",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Dipenkumar Modi, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Mayo Clinic Rochester",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "William Hogan, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                },
                {
                    "facility": "Washington University/Barnes Jewish Hospital",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ramzi Abboud, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Roswell Park Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Buffalo",
                    "state": "New York",
                    "zip": "14263",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Philip McCarthy, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.88645,
                        "lon": -78.87837
                    }
                },
                {
                    "facility": "Columbia University Medical Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ran Reshef, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Brian Shaffer, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "University of North Carolina Chapel Hill",
                    "status": "RECRUITING",
                    "city": "Chapel Hill",
                    "state": "North Carolina",
                    "zip": "27599",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Katarzyna Jamieson, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.9132,
                        "lon": -79.05584
                    }
                },
                {
                    "facility": "Levine Cancer Institute",
                    "status": "WITHDRAWN",
                    "city": "Charlotte",
                    "state": "North Carolina",
                    "zip": "28204",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.22709,
                        "lon": -80.84313
                    }
                },
                {
                    "facility": "Cincinnati Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45229",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ruby Khoury, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                },
                {
                    "facility": "Ohio State Medical Center, James Cancer Center",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43210",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Karilyn Larkin, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Hannah Choe, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                },
                {
                    "facility": "Oregon Health and Science University",
                    "status": "RECRUITING",
                    "city": "Portland",
                    "state": "Oregon",
                    "zip": "97239",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Rachel Cook, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.52345,
                        "lon": -122.67621
                    }
                },
                {
                    "facility": "University of Pennsylvania",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19104",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Alison Loren, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Thomas Jefferson University Sidney Kimmel Cancer Center",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19107",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Usama Gergis, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                },
                {
                    "facility": "Medical University of South Carolina",
                    "status": "RECRUITING",
                    "city": "Charleston",
                    "state": "South Carolina",
                    "zip": "29407",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Michelle Hudspeth, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.77657,
                        "lon": -79.93092
                    }
                },
                {
                    "facility": "TriStar BMT",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jeremy Pantin, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "TriStar Medical Group Children's Specialists",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37203",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Haydar Frangoul",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "Vanderbilt University Medical Center",
                    "status": "RECRUITING",
                    "city": "Nashville",
                    "state": "Tennessee",
                    "zip": "37232",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Bhagirathbhai Dholaria, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 36.16589,
                        "lon": -86.78444
                    }
                },
                {
                    "facility": "St. David's South Austin Medical Center",
                    "status": "RECRUITING",
                    "city": "Austin",
                    "state": "Texas",
                    "zip": "78704",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Aravind Ramakrishnan",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 30.26715,
                        "lon": -97.74306
                    }
                },
                {
                    "facility": "-Baylor College of Medicine - Texas Children's Hospital and Houston Methodist",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "George Carrum",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Texas Transplant Institute",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "37203",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Jose Carlos Cruz, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "University of Virginia",
                    "status": "RECRUITING",
                    "city": "Charlottesville",
                    "state": "Virginia",
                    "zip": "22903",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Karen Ballen, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.02931,
                        "lon": -78.47668
                    }
                },
                {
                    "facility": "Virginia Commonwealth University",
                    "status": "RECRUITING",
                    "city": "Richmond",
                    "state": "Virginia",
                    "zip": "23298",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "John McCarty, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.55376,
                        "lon": -77.46026
                    }
                },
                {
                    "facility": "University of Wisconsin Hospital and Clinic",
                    "status": "RECRUITING",
                    "city": "Madison",
                    "state": "Wisconsin",
                    "zip": "53792",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Aric Hall, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.07305,
                        "lon": -89.40123
                    }
                },
                {
                    "facility": "Froedtert & the Medical College of Wisconsin",
                    "status": "RECRUITING",
                    "city": "Milwaukee",
                    "state": "Wisconsin",
                    "zip": "53226",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Medhi Hamadani, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.0389,
                        "lon": -87.90647
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008223",
                    "term": "Lymphoma"
                },
                {
                    "id": "D000007938",
                    "term": "Leukemia"
                },
                {
                    "id": "D000011289",
                    "term": "Preleukemia"
                },
                {
                    "id": "D000054198",
                    "term": "Precursor Cell Lymphoblastic Leukemia-Lymphoma"
                },
                {
                    "id": "D000007945",
                    "term": "Leukemia, Lymphoid"
                },
                {
                    "id": "D000015451",
                    "term": "Leukemia, Lymphocytic, Chronic, B-Cell"
                },
                {
                    "id": "D000007951",
                    "term": "Leukemia, Myeloid"
                },
                {
                    "id": "D000015464",
                    "term": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive"
                },
                {
                    "id": "D000015470",
                    "term": "Leukemia, Myeloid, Acute"
                },
                {
                    "id": "D000009190",
                    "term": "Myelodysplastic Syndromes"
                },
                {
                    "id": "D000000208",
                    "term": "Acute Disease"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000008206",
                    "term": "Lymphatic Diseases"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000001855",
                    "term": "Bone Marrow Diseases"
                },
                {
                    "id": "D000011230",
                    "term": "Precancerous Conditions"
                },
                {
                    "id": "D000015448",
                    "term": "Leukemia, B-Cell"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000009196",
                    "term": "Myeloproliferative Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M5134",
                    "name": "Bone Marrow Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11220",
                    "name": "Lymphoma",
                    "asFound": "Lymphoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18116",
                    "name": "Leukemia, Lymphocytic, Chronic, B-Cell",
                    "asFound": "Chronic Lymphocytic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21314",
                    "name": "Hematologic Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M27585",
                    "name": "Precursor Cell Lymphoblastic Leukemia-Lymphoma",
                    "asFound": "Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10945",
                    "name": "Leukemia",
                    "asFound": "Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10951",
                    "name": "Leukemia, Lymphoid",
                    "asFound": "Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18123",
                    "name": "Leukemia, Myelogenous, Chronic, BCR-ABL Positive",
                    "asFound": "Chronic myelogenous leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14111",
                    "name": "Precancerous Conditions",
                    "relevance": "LOW"
                },
                {
                    "id": "M10955",
                    "name": "Leukemia, Myeloid",
                    "asFound": "Myelogenous Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18127",
                    "name": "Leukemia, Myeloid, Acute",
                    "asFound": "Acute Myelogenous Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M14164",
                    "name": "Preleukemia",
                    "asFound": "Myelodysplastic Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12145",
                    "name": "Myelodysplastic Syndromes",
                    "asFound": "Myelodysplastic Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M18118",
                    "name": "Leukemia, Biphenotypic, Acute",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11203",
                    "name": "Lymphatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M18115",
                    "name": "Leukemia, B-Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M3564",
                    "name": "Acute Disease",
                    "asFound": "Acute Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "M12149",
                    "name": "Myeloproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "T3543",
                    "name": "Lymphosarcoma",
                    "relevance": "LOW"
                },
                {
                    "id": "T1308",
                    "name": "Chronic Lymphocytic Leukemia",
                    "asFound": "Chronic Lymphocytic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T175",
                    "name": "Acute Lymphoblastic Leukemia",
                    "asFound": "Acute Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3533",
                    "name": "Lymphoblastic Lymphoma",
                    "asFound": "Lymphoblastic Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "asFound": "Chronic",
                    "relevance": "HIGH"
                },
                {
                    "id": "T1309",
                    "name": "Chronic Myeloid Leukemia",
                    "asFound": "Chronic myelogenous leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3995",
                    "name": "Myeloid Leukemia",
                    "asFound": "Myelogenous Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T182",
                    "name": "Acute Myeloid Leukemia",
                    "asFound": "Acute Myelogenous Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T188",
                    "name": "Acute Non Lymphoblastic Leukemia",
                    "asFound": "Acute Myelogenous Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3993",
                    "name": "Myelodysplastic Syndromes",
                    "asFound": "Myelodysplastic Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "T174",
                    "name": "Acute Leukemia of Ambiguous Lineage",
                    "asFound": "Mixed Phenotype Acute Leukemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T1311",
                    "name": "Chronic Myeloproliferative Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009173",
                    "term": "Mycophenolic Acid"
                },
                {
                    "id": "D000003520",
                    "term": "Cyclophosphamide"
                },
                {
                    "id": "D000008558",
                    "term": "Melphalan"
                },
                {
                    "id": "D000002066",
                    "term": "Busulfan"
                },
                {
                    "id": "C000024352",
                    "term": "Fludarabine"
                },
                {
                    "id": "D000016559",
                    "term": "Tacrolimus"
                }
            ],
            "ancestors": [
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000019653",
                    "term": "Myeloablative Agonists"
                },
                {
                    "id": "D000065095",
                    "term": "Calcineurin Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000000903",
                    "term": "Antibiotics, Antineoplastic"
                },
                {
                    "id": "D000000904",
                    "term": "Antibiotics, Antitubercular"
                },
                {
                    "id": "D000000995",
                    "term": "Antitubercular Agents"
                },
                {
                    "id": "D000000900",
                    "term": "Anti-Bacterial Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M6727",
                    "name": "Cyclophosphamide",
                    "asFound": "Effect of",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11541",
                    "name": "Melphalan",
                    "asFound": "Controlled Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M5336",
                    "name": "Busulfan",
                    "asFound": "Anesthetic",
                    "relevance": "HIGH"
                },
                {
                    "id": "M283230",
                    "name": "Fludarabine",
                    "asFound": "Rate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12128",
                    "name": "Mycophenolic Acid",
                    "asFound": "Whole",
                    "relevance": "HIGH"
                },
                {
                    "id": "M225513",
                    "name": "Fludarabine phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M18950",
                    "name": "Tacrolimus",
                    "asFound": "Term",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M17811",
                    "name": "Mesna",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M30452",
                    "name": "Calcineurin Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4222",
                    "name": "Anti-Bacterial Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4224",
                    "name": "Antibiotics, Antitubercular",
                    "relevance": "LOW"
                },
                {
                    "id": "M4311",
                    "name": "Antitubercular Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                }
            ]
        }
    },
    "hasResults": false
}